Setting

Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248396 | Pages: 170

Global clinical diagnostics market will reach $ 135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer. Highlighted with 82 tables and 94 figures, this 170-page report “Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Region. Based on Test, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Lipid Panel • Infectious Disease Testing • Liver Panel • Complete Blood Count (CBC) • Electrolyte Testing • Renal Panel • Other Tests Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Assay Kits & Reagents • Software & Services By Indication the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cardiovascular • Cancer • Infectious Disease • Stroke • Chronic Lower Respiratory Diseases • Diabetes • Other Indications By Patient Gender the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Male Patients • Female Patients By Age Group the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Age 44 and below • Age 45-64 • Age 65 and over By End User the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospital & Clinics Laboratory • Diagnostic Laboratory • Point-of-Care Testing • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Test, Product, and Indication, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: • Abbott Laboratories • Becton, Dickinson and Company • BioMerieux SA • Bio-Rad Laboratories Inc. • Bio-Reference Laboratories • Bioscientia Healthcare • Charles River Laboratories • Danaher Corporation • Hoffmann-La Roche AG • Hologic Inc. • Qiagen NV • Siemens Healthcare • Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	9
1.1 Industry Definition and Research Scope	9
1.1.1 Industry Definition	9
1.1.2 Research Scope	10
1.2 Research Methodology	13
1.2.1 Overview of Market Research Methodology	13
1.2.2 Market Assumption	14
1.2.3 Secondary Data	14
1.2.4 Primary Data	14
1.2.5 Data Filtration and Model Design	15
1.2.6 Market Size/Share Estimation	16
1.2.7 Research Limitations	17
1.3 Executive Summary	18
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	32
2.4 Emerging Opportunities and Market Trends	35
2.5 Porter’s Fiver Forces Analysis	39
3 Segmentation of Global Market by Test	43
3.1 Market Overview by Test	43
3.2 Lipid Panel	45
3.3 Infectious Disease Testing	46
3.4 Liver Panel	47
3.5 Complete Blood Count (CBC)	48
3.6 Electrolyte Testing	49
3.7 Renal Panel	50
3.8 Other Tests	51
4 Segmentation of Global Market by Product	52
4.1 Market Overview by Product	52
4.2 Instruments	54
4.3 Assay Kits & Reagents	55
4.4 Software & Services	56
5 Segmentation of Global Market by Indication	57
5.1 Market Overview by Indication	57
5.2 Cardiovascular	59
5.3 Cancer	60
5.4 Infectious Disease	61
5.5 Stroke	62
5.6 Chronic Lower Respiratory Diseases	63
5.7 Diabetes	64
5.8 Other Indications	65
6 Segmentation of Global Market by Patient Gender	66
6.1 Market Overview by Patient Gender	66
6.2 Male Patients	68
6.3 Female Patients	69
7 Segmentation of Global Market by Age Group	70
7.1 Market Overview by Age Group	70
7.2 Age 44 and below	72
7.3 Age 45-64	73
7.4 Age 65 and over	74
8 Segmentation of Global Market by End User	75
8.1 Market Overview by End User	75
8.2 Hospital & Clinics Laboratory	77
8.3 Diagnostic Laboratory	78
8.4 Point-of-Care Testing	79
8.5 Other End Users	80
9 Segmentation of Global Market by Region	81
9.1 Geographic Market Overview 2021-2031	81
9.2 North America Market 2021-2031 by Country	85
9.2.1 Overview of North America Market	85
9.2.2 U.S.	89
9.2.3 Canada	93
9.2.4 Mexico	95
9.3 European Market 2021-2031 by Country	97
9.3.1 Overview of European Market	97
9.3.2 Germany	101
9.3.3 U.K.	103
9.3.4 France	105
9.3.5 Spain	107
9.3.6 Italy	109
9.3.7 Russia	111
9.3.8 Rest of European Market	113
9.4 Asia-Pacific Market 2021-2031 by Country	115
9.4.1 Overview of Asia-Pacific Market	115
9.4.2 Japan	119
9.4.3 China	122
9.4.4 Australia	124
9.4.5 India	126
9.4.6 South Korea	128
9.4.7 Rest of APAC Region	130
9.5 South America Market 2021-2031 by Country	132
9.5.1 Argentina	135
9.5.2 Brazil	137
9.5.3 Chile	139
9.5.4 Rest of South America Market	141
9.6 MEA Market 2021-2031 by Country	142
9.6.1 UAE	145
9.6.2 Saudi Arabia	147
9.6.3 South Africa	149
9.6.4 Other National Markets	151
10 Competitive Landscape	152
10.1 Overview of Key Vendors	152
10.2 New Product Launch, Partnership, Investment, and M&A	155
10.3 Company Profiles	156
Abbott Laboratories	156
Becton, Dickinson and Company	158
BioMerieux SA	159
Bio-Rad Laboratories Inc.	160
Bio-Reference Laboratories	161
Bioscientia Healthcare	162
Charles River Laboratories	163
Danaher Corporation	164
Hoffmann-La Roche AG	165
Hologic Inc.	166
Qiagen NV	167
Siemens Healthcare	168
Thermo Fisher Scientific	169
RELATED REPORTS	170
List Of Tables:


Table 1.  Snapshot of Global Clinical Diagnostics Market in Balanced Perspective, 2021-2031	19
Table 2. World Economic Outlook, 2021-2031	23
Table 3. World Health Spending by Region, $ bn, 2013-2020	31
Table 4.  Main Product Trends and Market Opportunities in Global Clinical Diagnostics Market	35
Table 5. Global Clinical Diagnostics Market by Test, 2021-2031, $ mn	43
Table 6. Global Clinical Diagnostics Market by Product, 2021-2031, $ mn	52
Table 7. Global Clinical Diagnostics Market by Indication, 2021-2031, $ mn	57
Table 8. Global Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn	66
Table 9. Global Clinical Diagnostics Market by Age Group, 2021-2031, $ mn	70
Table 10. Global Clinical Diagnostics Market by End User, 2021-2031, $ mn	75
Table 11. Global Clinical Diagnostics Market by Region, 2021-2031, $ mn	82
Table 12.  Leading National Clinical Diagnostics Market, 2021 and 2031, $ mn	84
Table 13. North America Clinical Diagnostics Market by Country, 2021-2031, $ mn	87
Table 14. U.S. Clinical Diagnostics Market by Test, 2021-2031, $ mn	92
Table 15. U.S. Clinical Diagnostics Market by Product, 2021-2031, $ mn	92
Table 16. U.S. Clinical Diagnostics Market by Indication, 2021-2031, $ mn	92
Table 17. Canada Clinical Diagnostics Market by Test, 2021-2031, $ mn	94
Table 18. Canada Clinical Diagnostics Market by Product, 2021-2031, $ mn	94
Table 19. Canada Clinical Diagnostics Market by Indication, 2021-2031, $ mn	94
Table 20. Mexico Clinical Diagnostics Market by Test, 2021-2031, $ mn	96
Table 21. Mexico Clinical Diagnostics Market by Product, 2021-2031, $ mn	96
Table 22. Mexico Clinical Diagnostics Market by Indication, 2021-2031, $ mn	96
Table 23. Europe Clinical Diagnostics Market by Country, 2021-2031, $ mn	100
Table 24. Germany Clinical Diagnostics Market by Test, 2021-2031, $ mn	102
Table 25. Germany Clinical Diagnostics Market by Product, 2021-2031, $ mn	102
Table 26. Germany Clinical Diagnostics Market by Indication, 2021-2031, $ mn	102
Table 27. U.K. Clinical Diagnostics Market by Test, 2021-2031, $ mn	104
Table 28. U.K. Clinical Diagnostics Market by Product, 2021-2031, $ mn	104
Table 29. U.K. Clinical Diagnostics Market by Indication, 2021-2031, $ mn	104
Table 30. France Clinical Diagnostics Market by Test, 2021-2031, $ mn	106
Table 31. France Clinical Diagnostics Market by Product, 2021-2031, $ mn	106
Table 32. France Clinical Diagnostics Market by Indication, 2021-2031, $ mn	106
Table 33. Spain Clinical Diagnostics Market by Test, 2021-2031, $ mn	108
Table 34. Spain Clinical Diagnostics Market by Product, 2021-2031, $ mn	108
Table 35. Spain Clinical Diagnostics Market by Indication, 2021-2031, $ mn	108
Table 36. Italy Clinical Diagnostics Market by Test, 2021-2031, $ mn	110
Table 37. Italy Clinical Diagnostics Market by Product, 2021-2031, $ mn	110
Table 38. Italy Clinical Diagnostics Market by Indication, 2021-2031, $ mn	110
Table 39. Russia Clinical Diagnostics Market by Test, 2021-2031, $ mn	112
Table 40. Russia Clinical Diagnostics Market by Product, 2021-2031, $ mn	112
Table 41. Russia Clinical Diagnostics Market by Indication, 2021-2031, $ mn	112
Table 42. Clinical Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn	114
Table 43. APAC Clinical Diagnostics Market by Country, 2021-2031, $ mn	117
Table 44. Japan Clinical Diagnostics Market by Test, 2021-2031, $ mn	121
Table 45. Japan Clinical Diagnostics Market by Product, 2021-2031, $ mn	121
Table 46. Japan Clinical Diagnostics Market by Indication, 2021-2031, $ mn	121
Table 47. China Clinical Diagnostics Market by Test, 2021-2031, $ mn	123
Table 48. China Clinical Diagnostics Market by Product, 2021-2031, $ mn	123
Table 49. China Clinical Diagnostics Market by Indication, 2021-2031, $ mn	123
Table 50. Australia Clinical Diagnostics Market by Test, 2021-2031, $ mn	125
Table 51. Australia Clinical Diagnostics Market by Product, 2021-2031, $ mn	125
Table 52. Australia Clinical Diagnostics Market by Indication, 2021-2031, $ mn	125
Table 53. India Clinical Diagnostics Market by Test, 2021-2031, $ mn	127
Table 54. India Clinical Diagnostics Market by Product, 2021-2031, $ mn	127
Table 55. India Clinical Diagnostics Market by Indication, 2021-2031, $ mn	127
Table 56. South Korea Clinical Diagnostics Market by Test, 2021-2031, $ mn	129
Table 57. South Korea Clinical Diagnostics Market by Product, 2021-2031, $ mn	129
Table 58. South Korea Clinical Diagnostics Market by Indication, 2021-2031, $ mn	129
Table 59. Clinical Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn	131
Table 60. South America Clinical Diagnostics Market by Country, 2021-2031, $ mn	134
Table 61. Argentina Clinical Diagnostics Market by Test, 2021-2031, $ mn	136
Table 62. Argentina Clinical Diagnostics Market by Product, 2021-2031, $ mn	136
Table 63. Argentina Clinical Diagnostics Market by Indication, 2021-2031, $ mn	136
Table 64. Brazil Clinical Diagnostics Market by Test, 2021-2031, $ mn	138
Table 65. Brazil Clinical Diagnostics Market by Product, 2021-2031, $ mn	138
Table 66. Brazil Clinical Diagnostics Market by Indication, 2021-2031, $ mn	138
Table 67. Chile Clinical Diagnostics Market by Test, 2021-2031, $ mn	140
Table 68. Chile Clinical Diagnostics Market by Product, 2021-2031, $ mn	140
Table 69. Chile Clinical Diagnostics Market by Indication, 2021-2031, $ mn	140
Table 70. MEA Clinical Diagnostics Market by Country, 2021-2031, $ mn	144
Table 71. UAE Clinical Diagnostics Market by Test, 2021-2031, $ mn	146
Table 72. UAE Clinical Diagnostics Market by Product, 2021-2031, $ mn	146
Table 73. UAE Clinical Diagnostics Market by Indication, 2021-2031, $ mn	146
Table 74. Saudi Arabia Clinical Diagnostics Market by Test, 2021-2031, $ mn	148
Table 75. Saudi Arabia Clinical Diagnostics Market by Product, 2021-2031, $ mn	148
Table 76. Saudi Arabia Clinical Diagnostics Market by Indication, 2021-2031, $ mn	148
Table 77. South Africa Clinical Diagnostics Market by Test, 2021-2031, $ mn	150
Table 78. South Africa Clinical Diagnostics Market by Product, 2021-2031, $ mn	150
Table 79. South Africa Clinical Diagnostics Market by Indication, 2021-2031, $ mn	150
Table 80. Abbott Laboratories: Company Snapshot	156
Table 81. Abbott Laboratories: Business Segmentation	157
Table 82. Abbott Laboratories: Product Portfolio	157
List Of Figures:


Figure 1. Research Method Flow Chart	13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	18
Figure 4. Global Clinical Diagnostics Market, 2021-2031, $ mn	21
Figure 5. Impact of COVID-19 on Business	24
Figure 6. Primary Drivers and Impact Factors of Global Clinical Diagnostics Market	26
Figure 7.  Leading Causes of Death in the World, 2019-2020, million	29
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060	30
Figure 10. Primary Restraints and Impact Factors of Global Clinical Diagnostics Market	32
Figure 11. Investment Opportunity Analysis	36
Figure 12. Porter’s Fiver Forces Analysis of Global Clinical Diagnostics Market	39
Figure 13. Breakdown of Global Clinical Diagnostics Market by Test, 2021-2031, % of Revenue	44
Figure 14. Global Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%)	44
Figure 15. Global Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn	45
Figure 16. Global Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn	46
Figure 17. Global Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn	47
Figure 18. Global Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn	48
Figure 19. Global Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn	49
Figure 20. Global Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn	50
Figure 21. Global Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn	51
Figure 22. Breakdown of Global Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue	53
Figure 23. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)	53
Figure 24. Global Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn	54
Figure 25. Global Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn	55
Figure 26. Global Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn	56
Figure 27. Breakdown of Global Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue	58
Figure 28. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)	58
Figure 29. Global Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn	59
Figure 30. Global Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn	60
Figure 31. Global Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn	61
Figure 32. Global Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn	62
Figure 33. Global Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn	63
Figure 34. Global Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn	64
Figure 35. Global Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn	65
Figure 36. Breakdown of Global Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue	67
Figure 37. Global Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%)	67
Figure 38. Global Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn	68
Figure 39. Global Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn	69
Figure 40. Breakdown of Global Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue	71
Figure 41. Global Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%)	71
Figure 42. Global Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn	72
Figure 43. Global Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn	73
Figure 44. Global Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn	74
Figure 45. Breakdown of Global Clinical Diagnostics Market by End User, 2021-2031, % of Revenue	75
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	76
Figure 47. Global Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn	77
Figure 48. Global Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn	78
Figure 49. Global Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn	79
Figure 50. Global Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	80
Figure 51.  Global Market Snapshot by Region	81
Figure 52.  Geographic Spread of Worldwide Clinical Diagnostics Market, 2021-2031, % of Sales Revenue	82
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)	83
Figure 54.  North American Clinical Diagnostics Market, 2021-2031, $ mn	86
Figure 55. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	87
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	88
Figure 57. U.S. Clinical Diagnostics Market, 2021-2031, $ mn	90
Figure 58. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, %	90
Figure 59. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, %	91
Figure 60. Canada Clinical Diagnostics Market, 2021-2031, $ mn	93
Figure 61.  Clinical Diagnostics Market in Mexico, 2021-2031, $ mn	95
Figure 62.  European Clinical Diagnostics Market, 2021-2031, $ mn	98
Figure 63. Breakdown of European Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	99
Figure 64. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	100
Figure 65.  Clinical Diagnostics Market in Germany, 2021-2031, $ mn	101
Figure 66.  Clinical Diagnostics Market in U.K., 2021-2031, $ mn	103
Figure 67.  Clinical Diagnostics Market in France, 2021-2031, $ mn	105
Figure 68.  Clinical Diagnostics Market in Spain, 2021-2031, $ mn	107
Figure 69.  Clinical Diagnostics Market in Italy, 2021-2031, $ mn	109
Figure 70.  Clinical Diagnostics Market in Russia, 2021-2031, $ mn	111
Figure 71.  Clinical Diagnostics Market in Rest of Europe, 2021-2031, $ mn	113
Figure 72. Asia-Pacific Clinical Diagnostics Market, 2021-2031, $ mn	116
Figure 73. Breakdown of APAC Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	116
Figure 74. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	118
Figure 75.  Clinical Diagnostics Market in Japan, 2021-2031, $ mn	120
Figure 76.  Clinical Diagnostics Market in China, 2021-2031, $ mn	122
Figure 77.  Clinical Diagnostics Market in Australia, 2021-2031, $ mn	124
Figure 78.  Clinical Diagnostics Market in India, 2021-2031, $ mn	126
Figure 79.  Clinical Diagnostics Market in South Korea, 2021-2031, $ mn	128
Figure 80.  Clinical Diagnostics Market in Rest of APAC, 2021-2031, $ mn	130
Figure 81. South America Clinical Diagnostics Market, 2021-2031, $ mn	133
Figure 82. Breakdown of South America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	133
Figure 83. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	134
Figure 84.  Clinical Diagnostics Market in Argentina, 2021-2031, $ mn	135
Figure 85.  Clinical Diagnostics Market in Brazil, 2021-2031, $ mn	137
Figure 86.  Clinical Diagnostics Market in Chile, 2021-2031, $ mn	139
Figure 87.  Clinical Diagnostics Market in Rest of South America, 2021-2031, $ mn	141
Figure 88. Clinical Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn	143
Figure 89. Breakdown of MEA Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	143
Figure 90. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	144
Figure 91.  Clinical Diagnostics Market in UAE, 2021-2031, $ mn	145
Figure 92.  Clinical Diagnostics Market in Saudi Arabia, 2021-2031, $ mn	147
Figure 93.  Clinical Diagnostics Market in South Africa, 2021-2031, $ mn	149
Figure 94. Growth Stage of Global Clinical Diagnostics Industry over the Forecast Period	152
Selected Key Players: 
•	Abbott Laboratories
•	Becton, Dickinson and Company
•	BioMerieux SA
•	Bio-Rad Laboratories Inc.
•	Bio-Reference Laboratories
•	Bioscientia Healthcare
•	Charles River Laboratories
•	Danaher Corporation
•	Hoffmann-La Roche AG
•	Hologic Inc.
•	Qiagen NV
•	Siemens Healthcare
•	Thermo Fisher Scientific 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)